Pelvic Nerve Mobilization for Primary Dysmenorrhea
Primary dysmenorrhea is a highly prevalent condition among young women and is associated with significant pain, reduced quality of life, and academic absenteeism. Although non-steroidal anti-inflammatory drugs are commonly used, many women seek non-pharmacological alternatives due to limited effectiveness or adverse ef
| Condition(s) | Primary Dysmenorrhea (PD) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Primary dysmenorrhea is a highly prevalent condition among young women and is associated with significant pain, reduced quality of life, and academic absenteeism. Although non-steroidal anti-inflammatory drugs are commonly used, many women seek non-pharmacological alternatives due to limited effectiveness or adverse effects. Emerging evidence suggests that altered pelvic neurodynamics may contribute to dysmenorrheic pain. This randomized controlled trial aims to evaluate the effectiveness of external pelvic nerve mobilization in reducing menstrual pain and associated symptoms among university women with primary dysmenorrhea. Participants aged 18-30 years will be randomly allocated to receive either external pelvic nerve mobilization or a sham manual therapy intervention across three consec |
| Who can participate | Inclusion Criteria: * Female university students aged 18-30 years * Regular menstrual cycles (24-35 days) * Clinically diagnosed primary dysmenorrhea * Average menstrual pain intensity ≥ 5 on Visual Analog Scale * Willingness to participate and provide informed consent Exclusion Criteria: * Secondary dysmenorrhea (e.g., endometriosis, fibroids, pelvic inflammatory disease) * History of pelvic or spinal surgery * Neurological disorders * Current pregnancy or lactation * Current physiotherapy or manual therapy treatment * Contraindications to manual therapy |
| Ages | 18 Years to 30 Years |
| Sex | Female |
| Lead sponsor | University of Hail |
| Locations | Sialkot, Pakistan |
| Start date | 2025-10-20 |
| NCT ID | NCT07354451 |
| Official listing | https://clinicaltrials.gov/study/NCT07354451 |